Here’s how a Canadian businessman got Bill Clinton to help him get control of uranium mining fields in Kazahkstan, explains Peggy Noonan in the WSJ.
The businessman soon gave $31 million to the Clinton Foundation, with a pledge of $100 million more. Uranium One acquired significant holdings in the U.S. A Russian company moved to buy it. The deal needed U.S. approval, including from Secretary of State Hillary Clinton.
While it was under consideration the Clinton Foundation received more money from Uranium One. Bill Clinton got a $500,000 speech fee. Mrs. Clinton approved the deal. The Russian company is now one of the world’s largest uranium producers. Significant amounts of U.S. uranium are, in effect, owned by Russia. This summer a WikiLeaks dump showed the State Department warning that Russia was moving to control the global supply of nuclear fuel. The deal went through anyway, and the foundation flourished.
According to Peter Schweizer, who reported the Uranium One story in the WSJ, Mrs. Clinton pushed for a U.S.-Russian technology initiative whose goals included “the development of ties between the Russian and American people.”
“Mrs. Clinton looked for U.S. investors and found them,” writes Ms. Noonan. “Of the 28 announced ‘key partners,’ 60% had made financial commitments to the Clinton Foundation. Even Russian investors ponied up.”
As Hillary famously announced recently, “What difference does it make?”
Why don’t voters seem to know or care about this or any of the other loathsome activities pertaining to the Clintons? Because, as the WSJ’s Kimberley Strassel points out, “while both presidential candidates have plenty to answer for, the press has focused solely on taking out Mr. Trump. And the press is doing a diligent job of it.”
Peter Schweizer joins Lou Dobbs to discuss the explosive Wikileaks revelations
Latest posts by Debbie Young (see all)
- Obama’s Legacy: Monitor, Audit, Investigate Non-Progressives - October 15, 2018
- No Place for a Mob in a Constitutional Republic - October 12, 2018
- Spartacus Was a Hero, Not a Malignant Buffoon - October 12, 2018